SP1 and lipodystrophy: With a similar mechanism, accumulation of prelamin A by treatment of cells with anti-retroviral protease inhibitors, drugs that caused a lipodystrophy phenotype in patients subjected to therapy, has been shown to affect Sp1 import in nuclei of mesenchymal stem cells and Sp1-dependent regulation of genes related to lipid metabolism [18].